Unigestion Holding Sa Abbott Laboratories Transaction History

Unigestion Holding Sa

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.52 Million - $1.69 Million	-15,051 Reduced 56.39%	11,642 $1.21 Million
Q1 2024 May 08, 2024	BUY	$109.52 - $120.96 $1.65 Million - $1.82 Million	15,051 Added 129.28%	26,693 $3.03 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $568,647 - $696,072	-6,305 Reduced 35.13%	11,642 $1.28 Million
Q3 2023 Oct 31, 2023	BUY	$95.53 - $114.62 $122,278 - $146,713	1,280 Added 7.68%	17,947 $1.74 Million
Q2 2023 Jul 27, 2023	SELL	$100.78 - $112.29 $139,076 - $154,960	-1,380 Reduced 7.65%	16,667 $1.82 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $145,290 - $171,015	-1,500 Reduced 7.67%	18,047 $1.83 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $352,102 - $413,070	-3,704 Reduced 15.93%	19,547 $2.15 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $548,725 - $635,322	-5,671 Reduced 19.61%	23,251 $2.29 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $422,059 - $510,134	-4,135 Reduced 12.51%	28,922 $3.14 Million
Q1 2022 Apr 14, 2022	BUY	$114.02 - $139.04 $2.4 Million - $2.93 Million	21,060 Added 175.54%	33,057 $3.91 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.39 Million - $1.7 Million	11,997 New	11,997 $1.69 Million
Q3 2021 Oct 14, 2021	SELL	$116.66 - $129.06 $583,883 - $645,945	-5,005 Closed	0 $0
Q2 2021 Jul 29, 2021	SELL	$105.79 - $124.53 $740,106 - $871,211	-6,996 Reduced 58.3%	5,005 $587,000
Q1 2021 May 05, 2021	BUY	$108.84 - $128.23 $1.31 Million - $1.54 Million	12,001 New	12,001 $1.44 Million

3,336

1.36B

10M

9.48M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Unigestion Holding Sa, based on Form 13F filings with the SEC.

Stay updated on Unigestion Holding Sa with notifications on news.